These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 3752758

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Variceal sclerosing agents.
    Brooks WS.
    Am J Gastroenterol; 1984 May; 79(5):424-8. PubMed ID: 6609635
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The relationship of bacteremia to the length of injection needle in endoscopic variceal sclerotherapy.
    Snady H, Korsten MA, Waye JD.
    Gastrointest Endosc; 1985 Aug; 31(4):243-6. PubMed ID: 4029571
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Fatal Candida esophageal abscess and sepsis complicating endoscopic variceal sclerosis.
    Barthel JS, Sprouse RF, Dix JD, Sunderrajan EV.
    Gastrointest Endosc; 1987 Apr; 33(2):107-10. PubMed ID: 3569788
    [No Abstract] [Full Text] [Related]

  • 28. Sclerotherapy of oral and facial venous malformations with use of pingyangmycin and/or sodium morrhuate.
    Zhao JH, Zhang WF, Zhao YF.
    Int J Oral Maxillofac Surg; 2004 Jul; 33(5):463-6. PubMed ID: 15183410
    [Abstract] [Full Text] [Related]

  • 29. Endoscopic sclerotherapy versus esophageal transection of Child's class C patients with variceal hemorrhage. Comparison with results of portacaval shunt: preliminary report.
    Cello JP, Crass R, Trunkey DD.
    Surgery; 1982 Mar; 91(3):333-8. PubMed ID: 7036396
    [Abstract] [Full Text] [Related]

  • 30. Sodium morrhuate stimulates granulocytes and damages erythrocytes and endothelial cells: probable mechanism of an adverse reaction during sclerotherapy.
    Stroncek DF, Hutton SW, Silvis SE, Vercellotti GM, Jacob HS, Hammerschmidt DE.
    J Lab Clin Med; 1985 Nov; 106(5):498-504. PubMed ID: 4056566
    [Abstract] [Full Text] [Related]

  • 31. Decrease in FEV1 and FVC with sodium morrhuate esophageal sclerotherapy.
    Katz S, Schnader J, Britt EJ.
    Chest; 1986 Oct; 90(4):627. PubMed ID: 3757582
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The pulmonary hypertension of sclerosing agents is prevented by cyclooxygenase inhibitors.
    Hammond B, Fairman RP, Monroe P, Glauser FL, Sugarman H, Davis D.
    Am J Med Sci; 1985 Sep; 290(3):98-101. PubMed ID: 3931473
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Long-term follow-up of patients with liver cirrhosis after endoscopic esophageal varices ligation therapy: comparison with ethanol injection therapy.
    Okano H, Shiraki K, Inoue H, Kawakita T, Deguchi M, Sugimoto K, Sakai T, Ohmori S, Murata K, Nakano T.
    Hepatogastroenterology; 2003 Sep; 50(54):2013-6. PubMed ID: 14696455
    [Abstract] [Full Text] [Related]

  • 39. A Prospective Study of Endoscopic Injection Sclerotherapy and Endoscopic Variceal Ligation in the Treatment of Esophageal Varices.
    Ali SM, Wu S, Xu H, Liu H, Hao J, Qin C.
    J Laparoendosc Adv Surg Tech A; 2017 Apr; 27(4):333-341. PubMed ID: 28221819
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.